THURSDAY APRIL 15
07:45–08:00 Opening Ceremony
LIVE STREAM 1
08:00–09:15
Symposium SY01
Epidemiologic trends in melanoma
09:30–10:45
Symposium SY06
Controversies in dermato-oncology
11:00–12:30
Keynote Lecture KEY01
Systemic versus intralesional immunotherapy – different biology?
12:45–13:45
Satellite Symposium SAT02
Platinum Sponsor BMS
14:00–15:00
Symposium SY10
Advances in melanoma staging and prognosis: AJCC V8, integrative risk modeling, and beyond
15:15–16:15
Symposium SY14
Neoadjuvant treatment of melanoma
LIVE STREAM 2
08:00–09:15
Symposium SY02
Squamous cell carcinoma: epidemiology and management
09:30–10:30
Satellite Symposium SAT01
Gold Sponsor MSD
14:00–15:00
Satellite Symposium SAT03
Gold Sponsor Pierre Fabre
15:15–16:15
Symposium SY15
Immunotherapy of merkel cell carcinoma
16:30–17:30
Symposium SY18
Drug resistance to immune checkpoint inhibition
HALL A
08:00–09:15
Symposium SY03
Merkel cell carcinoma: epidemiology, surgery and radiology
09:30–10:30
Symposium SY07
Liquid biopsy
14:00–15:00
Symposium SY11
Epigenetic modulation in skin cancer
15:15–16:15
Satellite Symposium SAT04
NeraCare
16:30–17:30
Satellite Symposium SAT05
PeerVoice
17:45–19:15
Symposium SY19B
Registries for real world treatmentdata and outcome research
HALL B
08:00–09:00
Symposium SY04
Dermoscopy 1: total body photo-graphy, digital dermatoscopy and scanners: indications and procedures
9:30–10:45
Symposium SY08
Intralesional therapies of skin cancer
14:00–15:00
Symposium SY12
Adoptive T-cell transfer
15:15–16:15
Symposium SY16
Basal cell carcinoma: epidemiology and management
16:30–17:30
Symposium SY19
Artificial intelligence in medical oncology, pathology and radiology
17:45–18:45
Symposium SY19C
Drug resistance to targeted therapies
HALL C
08:00–09:15
Symposium SY05
Patient Advocates
09:30–10:30
Symposium SY09
Prognostic and predictive biomarkers in melanoma
14:00–15:00
Symposium SY13
Cutaneous lymphomas: what is new?
15:15–16:15
Symposium SY17
Ocular melanoma: similar and yet so different from other melanomas
16:30–17:30
Symposium SY19A
Skin Care in Organ Transplant Patients Europe (SCOPE)
FRIDAY APRIL 16
LIVE STREAM 1
08:00–09:00
Symposium SY20
Controversies in radiotherapy
09:15–10:15
Symposium SY24
Controversies in melanoma management
10:30–11:30
Symposium SY27
Adjuvant treatment of melanoma
11:45–12:45
Satellite Symposium SAT09
Platinum Sponsor Novartis
13:00–14:30
Keynote Lecture KEY02
Fundamental questions in dermato-oncology
14:45–15:45
Satellite Symposium SAT10
Platinum Sponsor
Sanofi Genzyme
16:00–17:00
Symposium SY31
Immune checkpoint inhibition for non-melanoma skin cancer
17:15–18:15
Symposium SY35
Highlights from AACR
LIVE STREAM 2
08:00–09:00
Symposium SY21
New druggable targets in ...
09:15–10:15
Satellite Symposium SAT07
Bronze Sponsor
Sanofi Genzyme / Regeneron
10:30–11:30
Symposium SY28
Sentinel node biopsy: techniques and future perspectives
16:00–17:00
Symposium SY32
Regulation of drug access across the world
17:15–18:15
Symposium SY36
Melanocytic nevi: risks and management
HALL A
8:00–9:00
Satellite Symposium SAT06
Skyline DX
10:30–11:30
Satellite Symposium SAT08
Sun Pharma
16:00–17:00
Satellite Symposium SAT11
Kyowa Kirin
17:15–18:00
Satellite Symposium SAT12
Almirall
HALL B
08:00–09:00
Symposium SY22
Management of mucosal melanoma
09:15–10:15
Symposium SY25
Molecular tumor board for skin cancer
10:30–11:30
Symposium SY29
Management of metastatic ocular melanoma
16:00–17:00
Symposium SY33
Immune checkpoint inhibition in immunocompromised patients
17:15–18:15
Symposium SY37
Promising agents for PD1-refractory patients
HALL C
08:00–09:00
Symposium SY23
Management of acral lentiginous melanomas
09:15–10:15
Symposium SY26
Quality assurance in dermato-oncology
10:30–11:30
Symposium SY30
Management of brain metastasis
16:00–17:00
Symposium SY34
New devices for skin cancer diagnostics
17:15–18:15
Symposium SY38
Triplets for advanced metastatic melanoma: still hope for the future?
SATURDAY APRIL 17
LIVE STREAM 1
09:00–10:00
Symposium SY39
Primary prevention of skin cancer
10:15–11:15
Keynote Lecture KEY03
Diagnostics
11:30–12:30
Symposium SY44
Interdisciplinary skin cancer centers: how they dealt with the Corona pandemic in different countries
12:45–13:45
Symposium SY49
Evidence-based skin cancer guidelines
14:00–15:30
Symposium SY54
Controversies in melanoma
15:45–17:15
Symposium SY58
Immunotherapies beyond checkpoint inhibition
LIVE STREAM 2
09:00–10:15
Symposium SY40
Management of lentigo maligna melanomas
11:30–12:30
Symposium SY45
Melanoma and Aging
12:45–13:45
Symposium SY50
Artificial intelligence in dermato-oncology
14:00–15:30
Symposium SY55
Actinic keratosis: recent treatment developments
15:45–17:15
Symposium SY59
Surgery of metastatic melanoma
HALL A
9:45–10:05
Satellite Symposium SAT13
La Roche-Posay
11:30–12:30
Satellite Symposium SAT14
Eucerin
12:45–13:45
Symposium SY51
Management of adverse events in targeted therapies
14:30–15:30
Satellite Symposium SAT15
Castle Bioscience
16:15–17:15
Satellite Symposium SAT16
Bronze Sponsor OncoSec
HALL B
09:00–10:00
Symposium SY42
Management of rare skin cancers
11:30–12:30
Symposium SY47
How to train young doctors in cutaneous oncology?
12:45–13:45
Symposium SY52
Is it as simple as making a cold tumor hot?
14:00–15:30
Symposium SY56
Dermoscopy 2: Dermoscopy in melanoma management
15:45–17:15
Symposium SY61
Dermoscopy 3: Difficult clinical scenarios
HALL C
09:00–10:00
Symposium SY43
Management of adverse events in immuno-oncology
11:30–12:30
Symposium SY48
Electrochemotherapy in dermato-oncology
12:45–13:45
Symposium SY53
Management of melanoma in pregnancy
14:00–15:30
Symposium SY57
Melanoma pathology – genomics and morphology
15:45–17:15
Symposium SY62
Genetic susceptibility of melanoma and cancer syndromes
17:15–17:25 Farewell and Poster Award